A Mechanism Exploration of Metabolic Syndrome Causing Nodular Thyroid Disease
Table 2
Anthropic and clinical characteristics of subjects with or without MS based on propensity score matching.
Variables
MS (n = 118)
Non-MS (n = 231)
SMD
Age (years)
51.96 (12.97)
50.03 (14.10)
0.215
0.143
Gender (female, n)
21 (17.8)
37 (16.0)
0.787
0.047
Body mass index (kg/m2)
27.36 (2.57)
23.78 (2.99)
<0.001
1.282
Systolic blood pressure (mmHg)
140.64 (16.95)
122.05 (14.65)
<0.001
1.173
Diastolic blood pressure (mmHg)
93.08 (9.81)
79.47 (10.97)
<0.001
1.307
Fasting blood sugar (mmol/L)
6.56 (1.80)
5.50 (1.01)
<0.001
0.727
Uric acid (mmol/L)
459.25 (111.30)
454.59 (104.83)
0.700
0.043
Creatinine (mmol/L)
79.87 (18.07)
81.56 (17.28)
0.397
0.095
Triglyceride (mmol/L)
2.41 (1.34)
1.51 (1.03)
<0.001
0.752
Cholesterol (mmol/L)
5.46 (0.91)
5.06 (0.90)
<0.001
0.440
High-density lipoprotein (mmol/L)
1.18 (0.26)
1.33 (0.32)
<0.001
0.513
Low-density lipoprotein (mmol/L)
3.22 (0.81)
3.05 (0.77)
0.061
0.211
Thyroid-stimulating hormone (mIU/L)
2.00 (1.02)
1.76 (0.85)
0.020
0.258
Free triiodothyronine (nmol/L)
5.21 (0.52)
5.26 (0.54)
0.398
0.096
Free thyroxine (nmol/L)
15.84 (2.10)
15.88 (2.14)
0.883
0.017
White blood cell (109 cells/L)
7.11 (2.12)
6.63 (1.80)
0.026
0.246
Neutrophil (109 cells/L)
3.91 (1.53)
3.68 (1.32)
0.138
0.164
Lymphocyte (109 cells/L)
2.57 (0.79)
2.33 (0.65)
0.003
0.326
Monocyte (109 cells/L)
0.43 (0.15)
0.42 (0.14)
0.516
0.072
Neutrophil/lymphocyte ratio
1.61 (0.63)
1.65 (0.61)
0.529
0.071
Lymphocyte/monocyte ratio
6.44 (2.29)
6.08 (2.83)
0.230
0.141
Monocyte/high-density lipoprotein ratio
0.38 (0.18)
0.34 (0.15)
0.008
0.293
Thyroid nodules (n)
73 (61.9)
108 (46.8)
0.010
0.307
Matching variables included age, gender, uric acid, and creatinine. Data were presented as mean (S.D.) or number (%). MS: metabolic syndrome; SMD: standardized mean difference.
